NCT03156647View on ClinicalTrials.gov

Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 16, 2020

Study Completion Date

July 16, 2020

Conditions
Parkinson DiseaseParkinsonian Disorders
Interventions
DIAGNOSTIC_TEST

Level of alpha-synuclein

Test of levels of total and ratio total:oligomeric in saliva

Trial Locations (3)

30029

CHU Nimes, Nîmes

34000

Hôpital Gui de Chauliac, Montpellier

Hôpital St Eloi, Montpellier

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT03156647 - Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome | Biotech Hunter | Biotech Hunter